Growth Metrics

Biogen (BIIB) Raw Materials (2016 - 2018)

Biogen has reported Raw Materials over the past 9 years, most recently at $196.3 million for Q4 2018.

  • Quarterly results put Raw Materials at $196.3 million for Q4 2018, up 20.87% from a year ago — trailing twelve months through Dec 2018 was $196.3 million (up 20.87% YoY), and the annual figure for FY2018 was $196.3 million, up 20.87%.
  • Raw Materials for Q4 2018 was $196.3 million at Biogen, up from $162.4 million in the prior quarter.
  • Over the last five years, Raw Materials for BIIB hit a ceiling of $213.0 million in Q4 2015 and a floor of $128.3 million in Q4 2014.
  • Median Raw Materials over the past 5 years was $170.4 million (2016), compared with a mean of $174.1 million.
  • Biggest five-year swings in Raw Materials: soared 66.02% in 2015 and later dropped 20.0% in 2016.
  • Biogen's Raw Materials stood at $128.3 million in 2014, then soared by 66.02% to $213.0 million in 2015, then decreased by 20.0% to $170.4 million in 2016, then fell by 4.69% to $162.4 million in 2017, then rose by 20.87% to $196.3 million in 2018.
  • The last three reported values for Raw Materials were $196.3 million (Q4 2018), $162.4 million (Q4 2017), and $170.4 million (Q4 2016) per Business Quant data.